Evidence map›Paper›PMID 36293373›Full record

ArticleInternational journal of molecular sciences2022

ERAP/HLA-C and KIR Genetic Profile in Couples with Recurrent Implantation Failure.

Karolina Piekarska, Paweł Radwan, Agnieszka Tarnowska, Michał Radwan, Jacek R Wilczyński, Andrzej Malinowski, Izabela Nowak

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Karolina PiekarskaLaboratory of Immunogenetics and Tissue Immunology, Department of Clinical Immunology, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wrocław, Poland.
Paweł RadwanDepartment of Reproductive Medicine, Gameta Hospital, 95-030 Rzgów, Poland.ORCID 0000-0002-9724-8517
Agnieszka TarnowskaLaboratory of Immunogenetics and Tissue Immunology, Department of Clinical Immunology, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wrocław, Poland.
Michał RadwanDepartment of Reproductive Medicine, Gameta Hospital, 95-030 Rzgów, Poland.
Jacek R WilczyńskiDepartment of Surgical and Oncological Gynecology, Medical University of Łódź, 93-513 Łódź, Poland.ORCID 0000-0002-2072-6533
Andrzej MalinowskiDepartment of Surgical, Endoscopic and Oncologic Gynecology, Polish Mothers' Memorial Hospital Research Institute, 93-338 Łódź, Poland.
Izabela NowakLaboratory of Immunogenetics and Tissue Immunology, Department of Clinical Immunology, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wrocław, Poland.ORCID 0000-0002-9127-1089
Ludwik Hirszfeld Institute of Immunology and Experimental Therapy · PLMedical University of Lodz · PLPolish Mother’s Memorial Hospital Research Institute · PL

Funding

National Science Centre 2014/13/B/NZ5/00273National Science Centre 2018/29/N/NZ5/00940
6 · The paper itself

Abstract

Proper embryo implantation depends on the tolerance of the maternal immune system to the fetus and its foreign paternal antigens. During implantation and early pregnancy, the dominant leukocytes in the uterus are uterine NK cells, expressing killer immunoglobulin-like receptors (KIR). KIRs recognize human leukocyte antigens (HLA-C) on the human trophoblast inherited from the father and mother. The antigenic peptides presented by the HLA are formed via their cleavage by endoplasmic reticulum aminopeptidases ERAP1 and ERAP2. The aim of this study was to assess the association of combined KIR genes and their HLA-C ligands, as well as ERAP1 and ERAP2 polymorphisms with recurrent implantation failure after in vitro fertilization (RIF). We tested 491 couples who underwent in vitro fertilization (IVF) and 322 fertile couples. Genotype CC rs27044 ERAP1 in female with a male’s HLA-C1C1 or HLA-C1C2 protected from RIF (p/pcorr. = 0.005/0.044, OR = 0.343; p/pcorr. = 0.003/0.027, OR = 0.442, respectively). Genotype TT rs30187 ERAP1 in female with a male’s HLA-C1C2 genotype increased the risk of RIF. Summarizing, in the combination of female ERAP1 and an HLA-C partner, the rs30187 C>T and rs27044 C>G polymorphisms play an important role in implantation failure.

Indexed as

Genetic ProfileHLA-C AntigensAminopeptidasesFemaleGenotypeHLA AntigensHumansImmunoglobulinsLigandsMaleMinor Histocompatibility AntigensPregnancyReceptors, KIRAminopeptidasesERAP1 protein, humanERAP2 protein, humanHLA AntigensHLA-C AntigensImmunoglobulinsLigandsMinor Histocompatibility AntigensReceptors, KIRERAPHLA-Cin vitro fertilizationKIRpolymorphismRIF

Identifiers

PMID36293373
PMCPMC9603896
OpenAlexW4306835875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.